BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 16719988)

  • 1. Endotoxin evaluation of eleven lipopolysaccharides by whole blood assay does not always correlate with Limulus amebocyte lysate assay.
    Dehus O; Hartung T; Hermann C
    J Endotoxin Res; 2006; 12(3):171-80. PubMed ID: 16719988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo lipopolysaccharide exposure of human blood leukocytes induces cross-tolerance to multiple TLR ligands.
    de Vos AF; Pater JM; van den Pangaart PS; de Kruif MD; van 't Veer C; van der Poll T
    J Immunol; 2009 Jul; 183(1):533-42. PubMed ID: 19542464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved bacterial clearance and decreased mortality can be induced by LPS tolerance and is not dependent upon IFN-gamma.
    Murphey ED; Fang G; Varma TK; Sherwood ER
    Shock; 2007 Mar; 27(3):289-95. PubMed ID: 17304110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-enterobacterial endotoxins stimulate human coronary artery but not venous endothelial cell activation via Toll-like receptor 2.
    Erridge C; Spickett CM; Webb DJ
    Cardiovasc Res; 2007 Jan; 73(1):181-9. PubMed ID: 17156768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipopolysaccharides from different bacterial sources elicit disparate cytokine responses in whole blood assays.
    Mathiak G; Kabir K; Grass G; Keller H; Steinringer E; Minor T; Rangger C; Neville LF
    Int J Mol Med; 2003 Jan; 11(1):41-4. PubMed ID: 12469215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance characteristics of the limulus amebocyte lysate assay and gas chromatography-mass spectrum analysis of lipopolysaccharides relative to nitric oxide production by peritoneal exudates of cells.
    Lin HH; Huang SP; Hsieh HC; Chen CS; Chen YL
    J Hazard Mater; 2007 Jul; 145(3):431-6. PubMed ID: 17188811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endotoxin potency in the A549 lung epithelial cell bioassay and the limulus amebocyte lysate assay.
    Hansen LA; Poulsen OM; Würtz H
    J Immunol Methods; 1999 Jun; 226(1-2):49-58. PubMed ID: 10410971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bartonella quintana lipopolysaccharide effects on leukocytes, CXC chemokines and apoptosis: a study on the human whole blood and a rat model.
    Matera G; Liberto MC; Quirino A; Barreca GS; Lamberti AG; Iannone M; Mancuso E; Palma E; Cufari FA; Rotiroti D; Focà A
    Int Immunopharmacol; 2003 Jun; 3(6):853-64. PubMed ID: 12781702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of the biologic responses of C3H/HEJ mice to endotoxin with the chemical and structural properties of the lipopolysaccharides from Pseudomonas aeruginosa and Escherichia coli.
    Pier GB; Markham RB; Eardley D
    J Immunol; 1981 Jul; 127(1):184-91. PubMed ID: 6787121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudomonas aeruginosa lipopolysaccharide induces osteoclastogenesis through a toll-like receptor 4 mediated pathway in vitro and in vivo.
    Zhuang L; Jung JY; Wang EW; Houlihan P; Ramos L; Pashia M; Chole RA
    Laryngoscope; 2007 May; 117(5):841-7. PubMed ID: 17473680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of endotoxins and other pyrogens using human whole blood.
    Fennrich S; Fischer M; Hartung T; Lexa P; Montag-Lessing T; Sonntag HG; Weigandt M; Wendel A
    Dev Biol Stand; 1999; 101():131-9. PubMed ID: 10566786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of mouse liver cytochrome P-450 by gram-negative bacteria lipopolysaccharides.
    Kaca W; Mara M; Ocenaskova J
    Arch Immunol Ther Exp (Warsz); 1996; 44(1):39-44. PubMed ID: 8874768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial proteins of granulocytes differ in interaction with endotoxin. Comparison of bactericidal/permeability-increasing protein, p15s, and defensins.
    Levy O; Ooi CE; Elsbach P; Doerfler ME; Lehrer RI; Weiss J
    J Immunol; 1995 May; 154(10):5403-10. PubMed ID: 7730641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
    Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
    Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-pseudomonas activity of anti-lipopolysaccharide hyperimmune equine plasma.
    Wells M; Gaffin SL
    Clin Exp Immunol; 1987 Apr; 68(1):86-92. PubMed ID: 3115643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The biological activity of a liposomal complete core lipopolysaccharide vaccine.
    Erridge C; Stewart J; Bennett-Guerrero E; McIntosh TJ; Poxton IR
    J Endotoxin Res; 2002; 8(1):39-46. PubMed ID: 11981444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyanobacterial LPS antagonist (CyP)-a novel and efficient inhibitor of Escherichia coli LPS-induced cytokine response in the pig.
    Thorgersen EB; Macagno A; Rossetti C; Mollnes TE
    Mol Immunol; 2008 Aug; 45(13):3553-7. PubMed ID: 18571239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptors and chondrocytes: the lipopolysaccharide-induced decrease in cartilage matrix synthesis is dependent on the presence of toll-like receptor 4 and antagonized by bone morphogenetic protein 7.
    Bobacz K; Sunk IG; Hofstaetter JG; Amoyo L; Toma CD; Akira S; Weichhart T; Saemann M; Smolen JS
    Arthritis Rheum; 2007 Jun; 56(6):1880-93. PubMed ID: 17530716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The isolation and characterization of lipopolysaccharides from Microcystis aeruginosa, a prominent toxic water bloom forming cyanobacteria.
    Bláhová L; Adamovský O; Kubala L; Švihálková Šindlerová L; Zounková R; Bláha L
    Toxicon; 2013 Dec; 76():187-96. PubMed ID: 24140921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly-purified Helicobacter pylori LPS preparations induce weak inflammatory reactions and utilize Toll-like receptor 2 complex but not Toll-like receptor 4 complex.
    Yokota S; Ohnishi T; Muroi M; Tanamoto K; Fujii N; Amano K
    FEMS Immunol Med Microbiol; 2007 Oct; 51(1):140-8. PubMed ID: 17645528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.